Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDChemomab Therapeutics Ltd. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 2 | -$0.01 | -$0.01 | -$0.01 |
| Q2 2025 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q3 2025 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q4 2025 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q1 2026 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q2 2026 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q3 2026 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q4 2026 | 1 | -$0.01 | -$0.01 | -$0.01 |
Chemomab Therapeutics Ltd. Earnings Date And Information
Chemomab Therapeutics Ltd. last posted its earnings results on Monday, March 3rd, 2025. The company reported $-0.16 earnings per share for the quarter, topping analysts' consensus estimates of $-0.2 by $0.04. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Chemomab Therapeutics Ltd. has generated $0 earnings per share over the last year ($-0.0009 diluted earnings per share) and currently has a price-to-earnings ratio of -0.07. Chemomab Therapeutics Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 7th, 2025 based on prior year's report dates.
Chemomab Therapeutics Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 12/31/2024 | Q4 2024 | N/A | -$0.16 | N/A | $0 | $0 |
| 09/30/2024 | Q3 2024 | N/A | -$0.01 | N/A | $0 | $0 |
| 08/21/2024 | Q2 2024 | -$0.20 | -$0.01 | 0.19 | $0 | $0 |
| 03/29/2024 | Q1 2024 | N/A | -$0.01 | N/A | N/A | $0 |
| 03/28/2024 | Q4 2023 | N/A | -$0.01 | N/A | N/A | $0 |
| 11/09/2023 | Q3 2023 | -$0.60 | -$0.02 | 0.58 | N/A | $0 |
| 08/14/2023 | Q2 2023 | -$0.80 | -$0.04 | 0.76 | N/A | $0 |
| 05/11/2023 | Q1 2023 | -$0.80 | -$0.04 | 0.76 | N/A | $0 |
| 03/20/2023 | Q4 2022 | -$0.80 | -$0.04 | 0.76 | N/A | $0 |
| 11/10/2022 | Q3 2022 | N/A | -$0.04 | N/A | N/A | $0 |
| 08/12/2022 | Q2 2022 | -$0.60 | -$0.03 | 0.57 | N/A | $0 |
| 05/12/2022 | Q1 2022 | -$0.40 | -$0.02 | 0.38 | N/A | $0 |
| 03/30/2022 | Q4 2021 | N/A | -$0.02 | N/A | N/A | $0 |
| 11/12/2021 | Q3 2021 | -$0.15 | -$0.01 | 0.13 | N/A | $0 |
| 08/13/2021 | Q2 2021 | -$0.12 | -$0.01 | 0.1 | N/A | $0 |
| 05/13/2021 | Q1 2021 | -$0.43 | -$0.01 | 0.42 | N/A | $0 |
| 03/09/2021 | Q4 2020 | N/A | -$0.06 | N/A | N/A | $0 |
| 11/16/2020 | Q3 2020 | N/A | -$0.07 | N/A | N/A | $0 |
| 08/14/2020 | Q2 2020 | N/A | -$0.09 | N/A | N/A | $0 |
| 05/07/2020 | Q1 2020 | -$1.84 | -$0.10 | 1.74 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Chemomab Therapeutics Ltd. Earnings: FAQ's
Chemomab Therapeutics Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 7th, 2025 based offlast year's report dates.
In the previous quarter, Chemomab Therapeutics Ltd. (:CMMB) reported $-0.16 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.2 by $0.04.
The conference call for Chemomab Therapeutics Ltd.'s latest earnings report can be listened to online.
The conference call transcript for Chemomab Therapeutics Ltd.'s latest earnings report can be read online.
Chemomab Therapeutics Ltd. (:CMMB) has a recorded net income of $-13,945.Chemomab Therapeutics Ltd. has generated $-0.0009 earnings per share over the last four quarters.
Chemomab Therapeutics Ltd. (:CMMB) has a price-to-earnings ratio of -0.07 and price/earnings-to-growth ratio is 0.